| Vifor (International) Inc. - Celldemic, Injektionssuspension in Fertigspritzen | | 69948 | | 01 | | Celldemic | | Injektionssuspension in Fertigspritzen | | J07BB02 | | Influenza, Inactivated, Split Virus Or Surface Antigen | | 25.06.2026 | | |
| | Composition | | haemagglutininum influenzae A (H5N1) (Virus-Stamm A/turkey/Turkey/1/2005 NIBRG-23) 7.5 µg, adjuvans: squalenum, polysorbatum 80 1.175 mg, sorbitani trioleas, natrii citras dihydricus et acidum citricum, natrii chloridum, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, magnesii chloridum hexahydricum, aqua ad iniectabile, q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.88 mg, kalium 0.1 mg. | | Packungsbestandteile | | | | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 10 | | | B | | No |
|
|
